| Financial Year |
March 31 2023 |
| Monetary Funds |
184,927,238.02 |
| Held-for-trading Financial Assets |
20,098,333.33 |
| Notes Receivable |
43,279,409.96 |
| Accounts Receivable |
18,867,109.01 |
| Advances to Suppliers |
3,412,757.11 |
| Other Receivables |
31,628,260.40 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
133,364,483.70 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
2,399,944.05 |
| Other Current Assets |
780,847.92 |
| Total Current Assets |
525,508,957.45 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
6,854,621.05 |
| Long-term Equity Investment |
-- |
| Investment Properties |
16,955,672.70 |
| Fixed Assetes |
262,809,746.73 |
| Under-construction Projects |
20,652,084.93 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
155,885,816.63 |
| R&D expenses |
-- |
| Goodwill |
137,143,972.34 |
| Long-Term Deferred and Prepaid Expenses |
2,780,695.80 |
| Deferred Income Tax Assets |
4,749,620.74 |
| Other Non-Current Assets |
1,170,180.00 |
| Sub-Total of Non-Current Assets |
635,355,656.73 |
| Total Assets |
1,160,864,614.18 |
| Short-Term Loans |
35,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
11,891,037.90 |
| Accounts Payable |
61,123,612.42 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
16,750,447.86 |
| Taxes Payable |
5,148,474.02 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
49,295,039.65 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
12,610,022.70 |
| Other Current Liabilities |
9,615,618.34 |
| Sub-Total of Current Liabilities |
258,131,115.22 |
| Long-term Loans |
90,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
7,056,698.57 |
| Other Non-Current Liabilities |
658,921.34 |
| Sub-Total of Non-Current Liabilities |
193,631,117.14 |
| Total Liabilities |
451,762,232.36 |
| Paid-In Capital(Or Share Stock) |
239,471,267.00 |
| Capital Surplus |
474,064,292.56 |
| Surplus Reserve |
45,898,527.36 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-54,380,866.55 |
| Minority Stockholder's Interest |
4,049,161.45 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
705,053,220.37 |
| Owner's Equity（Stockholder's Equity） |
709,102,381.82 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,160,864,614.18 |
